Cytokinetics of a human neuroblastoma cell line following treatment with dianhydrogalactitol.

Studies were carried out on the effect of dianhydrogalactitol on a human neuroblastoma cell line in culture. The drug was cytotoxic at concentrations of 5 micrograms/ml and 10 micrograms/ml for 1 hour, but not at 1 microgram/ml. Flow cytometry of DNA showed that cell kill was preceded by a transient accumulation of cells in early S at 10 hours, and in late S at 36 hours. Smaller increases in the percent of cells in S phase were seen after treatment with 1 microgram/ml, without cell kill. It may be concluded that dianhydrogalactitol causes an S-phase block, followed by death of cells in late S at concentrations above 5 micrograms/ml.

[1]  M. Melamed,et al.  Luminescence of the solid complexes of acridine orange with RNA. , 2005, Cytometry.

[2]  K. Bauer,et al.  Total cellular RNA content: correlation between flow cytometry and ultraviolet spectroscopy. , 1980, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  M. Melamed,et al.  Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. , 1980, Blood.

[4]  T. Fleming,et al.  Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma. , 1979, JAMA.

[5]  D. Deen,et al.  Perturbed cell kinetics of 9L rat brain tumor cells following dianhydrogalactitol. , 1978, Cancer treatment reports.

[6]  M. Walker,et al.  Phase II study of dianhydrogalactitol in malignant glioma. , 1978, Cancer treatment reports.

[7]  P. Coulson,et al.  Quantitation of cellular deoxyribonucleic acid by flow microfluorometry. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  S. Barranco,et al.  Cell killing, kinetics, and recovery responses induced by 1,2:5,6-dianhydrogalactitol in dividing and nondividiing cells in vitro. , 1977, Journal of the National Cancer Institute.

[9]  M. Melamed,et al.  Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  Levin Va,et al.  Dianhydrogalactitol (NSC-132313): pharmacokinetics in normal and tumor-bearing rat brain and antitumor activity against three intracerebral rodent tumors. , 1976 .

[11]  M. Melamed,et al.  Conformation of RNA in situ as studied by acridine orange staining and automated cytofluorometry. , 1975, Experimental cell research.

[12]  S. Das,et al.  Human neuroblastoma in nude mice. , 1975, Cancer research.

[13]  B. Spengler,et al.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. , 1973, Cancer research.

[14]  Z. Szentirmay,et al.  Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313). , 1972, Cancer chemotherapy reports.

[15]  E. Csanyi,et al.  Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma. , 1967, British Journal of Cancer.

[16]  H. Bisel,et al.  Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors. , 1981, Oncology.

[17]  P. Rózsa,et al.  Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation. , 1980, Cancer treatment reports.

[18]  I. Pályi.  Survival and phase sensitivity of HeLa cells treated with dianhydrogalactitol (NSC-132313). , 1975, Cancer chemotherapy reports.

[19]  L. Németh,et al.  Investigation into the correlation of cytostatic activity with the in vitro diepoxide formation on some terminally substituted hexitols. , 1970, Neoplasma.